153 related articles for article (PubMed ID: 9434274)
1. Biological activity of lysozyme after entrapment in poly(d,l-lactide-co-glycolide)-microspheres.
Ghaderi R; Carlfors J
Pharm Res; 1997 Nov; 14(11):1556-62. PubMed ID: 9434274
[TBL] [Abstract][Full Text] [Related]
2. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of a novel bioactive glass/lysozyme/PLGA composite microsphere.
Liu H; Shi S; Cao J; Ji L; He Y; Xi J
Drug Dev Ind Pharm; 2015 Mar; 41(3):458-63. PubMed ID: 24471512
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
[TBL] [Abstract][Full Text] [Related]
6. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
Cho M; Sah H
J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
[TBL] [Abstract][Full Text] [Related]
7. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
[TBL] [Abstract][Full Text] [Related]
8. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
Shiga K; Muramatsu N; Kondo T
J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
[TBL] [Abstract][Full Text] [Related]
9. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of protein in PLG-microspheres with retention of bioactivity.
Sturesson C; Carlfors J
J Control Release; 2000 Jul; 67(2-3):171-8. PubMed ID: 10825551
[TBL] [Abstract][Full Text] [Related]
11. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load.
Ravivarapu HB; Lee H; DeLuca PP
Pharm Dev Technol; 2000; 5(2):287-96. PubMed ID: 10810758
[TBL] [Abstract][Full Text] [Related]
12. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
13. Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres.
Lee ES; Park KH; Kang D; Park IS; Min HY; Lee DH; Kim S; Kim JH; Na K
Biomaterials; 2007 Jun; 28(17):2754-62. PubMed ID: 17337049
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
15. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles.
Srinivasan C; Katare YK; Muthukumaran T; Panda AK
J Microencapsul; 2005 Mar; 22(2):127-38. PubMed ID: 16019899
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
[TBL] [Abstract][Full Text] [Related]
17. Lysozyme microencapsulation within biodegradable PLGA microspheres: urea effect on protein release and stability.
Nam YS; Song SH; Choi JY; Park TG
Biotechnol Bioeng; 2000 Nov; 70(3):270-7. PubMed ID: 10992231
[TBL] [Abstract][Full Text] [Related]
18. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution.
Raman C; Berkland C; Kim K; Pack DW
J Control Release; 2005 Mar; 103(1):149-58. PubMed ID: 15773062
[TBL] [Abstract][Full Text] [Related]
19. About mean diameter and size distributions of poly(lactide-co-glycolide) (PLG) microspheres.
Berchane NS; Jebrail FF; Carson KH; Rice-Ficht AC; Andrews MJ
J Microencapsul; 2006 Aug; 23(5):539-52. PubMed ID: 16980275
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
